CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that the LifeVest® Wearable Defibrillator was discussed in nine scientific presentations and posters at the Heart Rhythm Society’s 31st Annual Scientific Sessions in Denver, Colorado last week. The LifeVest presentations given at this premier international meeting of cardiac arrhythmia professionals illustrate the role of the LifeVest as an emerging standard of care to protect patients during their changing medical condition, and until their permanent risk of sudden cardiac arrest (SCA) is established.
